on PharmaSGP Holding SE (isin : DE000A2P4LJ5)
PharmaSGP Announces Delisting Agreement with FUTRUE GmbH
On June 10, 2025, PharmaSGP Holding SE entered a delisting agreement with its majority shareholder, FUTRUE GmbH. The agreement includes an unconditional public delisting tender offer at EUR 28.00 per PharmaSGP share, exceeding the six-month average share price.
PharmaSGP plans to revoke its shares' admission to trading on the Frankfurt Stock Exchange, given its limited free float and high administrative costs. The Bidder intends a squeeze-out of minority shareholders and a profit and loss transfer agreement with PharmaSGP post-delisting.
The offer document's release will follow regulatory approval. Investors are strongly recommended to review all relevant documents, noting that the offer adheres exclusively to German and certain U.S. securities laws.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all PharmaSGP Holding SE news